Efficacy of abatacept, a selective co-stimulation modulator, in oxazolone-induced colitis

被引：0
|
作者：
Yang, Xiaoxia
Stetsko, Dawn
Xie, Jenny
Nadler, Steve
Suchard, Suzanne
Salter-Cid, Luisa
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A227 / A227
页数：1
相关论文
共 50 条
  • [31] Bone marrow-derived innate macrophages attenuate oxazolone-induced colitis
    Cheng, Zhao
    Peng, Hong-ling
    Zhang, Rong
    Fu, Xian-ming
    Zhang, Guang-sen
    CELLULAR IMMUNOLOGY, 2017, 311 : 46 - 53
  • [32] Efficacy and safety of the selective co-stimulation modulator abatacept with methotrexate for treating rheumatoid arthritis: 1-year clinical and radiographic results from the phase III AIM (Abatacept in inadequate responders to methotrexate trial.
    Kremer, J
    Westhovens, R
    Moreland, L
    Emery, P
    Russell, A
    Ge, ZY
    Aranda, R
    Becker, FC
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4095 - 4095
  • [33] Significant and sustained clinical efficacy demonstrated by the selective co-stimulation modulator abatacept in combination with Methotrexate (MTX) over 3 years in Rheumatoid Arthritis (RA) patients with an inadequate response to MTX
    Emery, P.
    Westhovens, R.
    Russell, A.
    Moreland, L.
    Becker, J. -C.
    Teng, J.
    Zhou, Y.
    Kremer, J.
    RHEUMATOLOGY, 2006, 45 : I40 - I41
  • [34] Beneficial effects of the selective CO-stimulation modulator abatacept on biomarkers of rheumatoid arthritis immunopathology in patients with an inadequate response to methotrexate or TNF-inhibitor treatment
    Emery, R
    Westhovens, R
    Leon, G
    Nuamah, I
    Ge, Z
    Aranda, R
    Becker, J
    Genovese, M
    Dougados, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 432 - +
  • [35] The study for the role of self-made decoction of TCM on mice with oxazolone-induced colitis
    Ye, C. Y.
    Ouyang, Q.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 107 - 107
  • [36] Correction: Intestinal vitamin D receptor knockout protects from oxazolone-induced colitis
    Yongyan Shi
    Ziyun Liu
    Xuewei Cui
    Qun Zhao
    Tianjing Liu
    Cell Death & Disease, 11
  • [37] Beneficial effects of the selective co-stimulation modulator abatacept on biomarkers of rheumatoid arthritis immunopathology in patients with an inadequate response to methotrexate or TNF-inhibitor treatment
    Haraoui, B
    Emery, P
    Aranda, R
    Becker, JC
    Dougados, M
    Garza, M
    Teng, J
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 393 - 393
  • [38] Therapeutic efficacy and mechanism of water-soluble extracts of Banxiaxiexin decoction on BALB/c mice with oxazolone-induced colitis
    Wang, Xuewei
    Yang, Jinghui
    Cao, Qin
    Tang, Jianmin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (04) : 1201 - 1204
  • [39] Improvement effect of compound Ento-PB on oxazolone-induced ulcerative colitis in rats
    Fan, Zhi
    Chen, Jinhu
    Wei, Jia
    Yang, ZhiBin
    Xiao, Huai
    Liu, Heng
    ACTA CIRURGICA BRASILEIRA, 2024, 39
  • [40] Tetramethylpyrazine attenuates PPAR-γ antagonist-deteriorated oxazolone-induced colitis in mice
    He, Xiangyi
    Zheng, Zhong
    Yang, Xiangyi
    Lu, Yunmin
    Chen, Niwei
    Chen, Weixiong
    MOLECULAR MEDICINE REPORTS, 2012, 5 (03) : 645 - 650
12345